Zombified Government Spending

The huge rally on Wednesday of last week fizzled by the end of the week.

What a week. Full of sound and fury…signifying nothing.

Wednesday’s rally was the “seventh best day for the DJIA in 110 years,” reports our Bonner Family Office analyst, Chris Hunter. “And sure, this sounds pretty impressive. But it’s useful to bear in mind that the best day in history for the DJIA was on October 13, 2008 (when the index shot up 936 points). In the next few days the DJIA was down 11%. Then it shot up again by 15%. Then it nosedived by 25%. The next best day after that for the index was October 28, 2008. And the sixth best day came six days after the top of the Nasdaq bubble, on March 16, 2000.”

Yes, dear reader, the pride of a big rally is what goeth before the fall of a big dip. Or worse.

House prices were down again for another month — making 15 out of the last 16 with falling prices.

But last week’s news was mostly good. Unemployment went down. House sales went up. Manufacturing data was mostly good…unless you looked at the trends in Europe, which were all bad.

And the shopping news was mostly good too… Auto sales were healthy, said the papers. Gasoline was selling for under $3 a gallon.

All of which could lead a determined hallucinator to imagine that the whole Great Correction thing had been called off.

Wouldn’t that be something, dear reader? What if we weren’t just wrong about the details but about the whole shebang? What if the number of new job offers continued to increase? What if consumers continued to buy things? What if Europe got control of its debt problem…and America’s economy began to really grow again?

But wait…the growth of the last 30 years came from the government spending money we didn’t have. In Europe, the government spent it. In America, households spent it. In Britain, both spent it.

Could that happen again? Certainly, that’s what the feds are aiming for…by reducing rates in Europe and lending at zero in the US. And bailing out big debtors. Heck, we won’t rule out anything.

But there must be limits on how much debt an economy can take. And by all indications, we blew by those limits long ago. Take the whole developed world. Put together its debts. Those debts grew at an 11% rate throughout the last decade, nearly 3 times faster than GDP. Now, they’re 310% of GDP.

You’d think that would be enough to sink the planet into a global depression. At a 5% interest rate, the carrying cost of that debt equals 15.5% of total output. That’s zombie finance — paying for toys for children who are now grown up…and trips for people who are now dead. It’s as if the average working stiff were putting in nearly one day a week just to pay the costs of the past.

Government finances are the most zombified of all — as you would expect. In the US, for example, taxpayers pony up about $2.1 trillion per year. But the feds owe $15 trillion. This puts the ratio of revenue to debt at about 1 to 7. At 5% carrying costs, it would cost the feds $750,000,000,000 per year in interest — or about a third of tax revenues. That would leave only about $1.35 trillion to cover the costs of federal government spending — which is now at $3.5 trillion per year.

And it’s worse. Because the feds also have to roll over about 40% of their debt in the next three years.

Of course, the rest of government spending is zombified too. Into our office on Friday walked a dear reader. It turned out he was a doctor, author of many textbooks on natural remedies and alternative cures and once a very high-ranking official at the National Institution of Health.

“Zombified?” he began. “You don’t know the half of it. Just drive up that bio-tech corridor north of Washington. It’s filled with gleaming office buildings. Many of them are bio-tech businesses.

“What a business! Their research is done at taxpayer expense by the NIH…or funded by it. They come out with these shock and awe new drugs. And then, investors think they’ve got an Aspirin, Motrin or Viagra on their hands. So they go into the marketplace and sell billions in shares to investors. And then, they sell the patented drugs back to the government. The US government is the biggest drug buyer in the world. And it doesn’t quibble on prices. Because a lot of the people who work at NIH and other health bureaucracies know that if they want to make real money they’ll move up the road to the bio-tech companies…and with the salary and options they have a chance of making beaucoup money. It’s all very cozy.

“And the real story is that the pharmaceutical industry rarely comes out with a really effective and safe drug. When I go to the doctors I ask for a prescription for drugs that were developed in the ’70s. Not just because they’re much cheaper…but because they now have 40 years of experience with them. We know which ones are reliable and which are dangerous. We don’t know that with the new drugs. And most really aren’t very effective anyway.”

Not to be distracted…we return to our theme. Can such a corrupt, zombified and heavily-indebted world suddenly sprint ahead?

Normally, it would have to shuck off its burden of debt. Normally, the zombies would have to find honest employment first. We will keep an open mind, but our guess is that the smart money is still selling stocks on rallies…and buying gold on dips, not the other way around.


Bill Bonner
for Markets and Money

Bill Bonner

Bill Bonner

Best-selling investment author Bill Bonner is the founder and president of Agora Publishing, one of the world's most successful consumer newsletter companies. Owner of both Fleet Street Publications and MoneyWeek magazine in the UK, he is also author of the free daily e-mail Markets and Money.
Bill Bonner

Latest posts by Bill Bonner (see all)

Leave a Reply

Be the First to Comment!

Notify of
Letters will be edited for clarity, punctuation, spelling and length. Abusive or off-topic comments will not be posted. We will not post all comments.
If you would prefer to email the editor, you can do so by sending an email to letters@dailyreckoning.com.au